跳至主要内容
临床试验/NCT01612806
NCT01612806终止不适用

A Multi-center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold, PriMatrix Ag Antimicrobial Dermal Repair Scaffold, and Standard of Care for the Treatment of Venous Leg Ulcers

Integra LifeSciences Corporation10 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
31
试验地点
10
主要终点
Percent of VLUs healed by week 12 post-randomization

研究概览

简要总结

To evaluate the effectiveness of PriMatrix, PriMatrix Ag, and Standard of Care in the treatment of venous leg ulcers (VLUs).

详细描述

Healing percentages

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women ≥ 18 years of age
  • Ankle-brachial index (ABI) > 0.80
  • Study wound 2-64 cm2 surface area
  • Wound does not exhibit a greater than 50% reduction in surface area during the screening period

排除标准

  • Suspected or confirmed signs/symptoms of wound infection
  • Hypersensitivity to bovine collagen
  • Body Mass Index (BMI) ≥ 45

结局指标

主要结局

Percent of VLUs healed by week 12 post-randomization

时间窗: 12 weeks

次要结局

  • Cost of treatment(12 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验